CTOs on the Move

StriVectin

www.strivectin.com

 
Our mission is simple. Deliver the most high-performance skincare and haircare solutions powered by the latest clinical advances to transform the look of your skin and hair. At the center of every formula is patented, proprietary NIA-114 technology that supercharges StriVectin`s clinically proven, award winning products.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.strivectin.com
  • 601 West 26th Street Suite 1505
    New York, NY USA 10001
  • Phone: 800.430.0227

Executives

Name Title Contact Details

Similar Companies

Monument

Monument is an online treatment platform for those looking to change their relationship with alcohol.

Banyan Hypnosis Ctr-Training

Banyan Hypnosis Ctr-Training is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biotechnology Council of New Jersey

Biotechnology Council of New Jersey, Inc. is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.

Lifespire

Lifespire's Day Treatment facilities provide state of the art therapeutic services for people with severe cognitive and physical challenges. The emphasis of Lifespire's coordinated therapeutic approach is to first assess each person's needs, preferences,